ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

XOMAP XOMA Corporation

25.31
0.00 (0.00%)
May 31 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
XOMA Corporation XOMAP NASDAQ Preference Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 25.31 19:00:00
Open Price Low Price High Price Close Price Previous Close
25.31 25.31
more quote information »

Recent News

Date Time Source Heading
5/30/202415:43EDGAR2Form 8-K - Current report
5/17/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/17/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/17/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/17/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/17/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/17/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/16/202406:31EDGAR2Form 8-K - Current report
5/14/202406:30GLOBEXOMA to Present at H.C. Wainwright 2nd Annual Bioconnect..
5/09/202406:45EDGAR2Form 8-K - Current report
5/09/202406:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:30GLOBEXOMA Reports First Quarter 2024 Financial Results and..
4/30/202406:30GLOBEXOMA Adds Economic Interests in Three First-in-Category..
4/25/202406:30GLOBEXOMA Earns $9 Million Milestone as FDA Grants Accelerated..
4/03/202408:00GLOBEXOMA Corporation Announces Closing of Tender Offer
3/21/202406:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
3/19/202415:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
3/11/202405:56EDGAR2Form S-4 - Registration of securities, business combinations
3/08/202415:34EDGAR2Form S-3 - Registration statement under Securities Act of..
3/08/202406:39EDGAR2Form 8-K - Current report
3/08/202406:30GLOBEXOMA Reports Fourth Quarter and Full Year 2023 Financial..
3/04/202416:24EDGAR2Form SC TO-T - Tender offer statement by Third Party
2/28/202406:30GLOBEXOMA to Present at Upcoming Investor Conferences in March
2/16/202408:08EDGAR2Form 8-K - Current report
2/16/202407:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
1/18/202407:30GLOBEXOMA Expands its Commercial Royalty and Milestone Portfolio..
1/16/202416:22EDGAR2Form SC 13D/A - General statement of acquisition of..
1/11/202415:31EDGAR2Form 8-K - Current report
1/11/202415:05GLOBEFDA Acceptance of Zevra’s Arimoclomol NDA Filing for..
1/10/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:30GLOBEXOMA Names Owen Hughes as Chief Executive Officer and..
1/02/202406:46EDGAR2Form 8-K - Current report
1/02/202406:30GLOBEXOMA Announces Stock Repurchase Program of up to $50 Million
12/20/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
12/19/202306:40EDGAR2Form 8-K - Current report
12/19/202306:30GLOBEXOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse..
11/07/202306:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202306:40EDGAR2Form 8-K - Current report
11/07/202306:30GLOBEXOMA Reports Third Quarter 2023 Financial Results and..
10/31/202306:35EDGAR2Form 8-K - Current report
10/31/202306:30GLOBEXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day..
10/27/202316:06EDGAR2Form 8-K - Current report
10/04/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/27/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
9/11/202315:10EDGAR2Form 8-K - Current report
9/06/202306:30GLOBEXOMA to Present at H.C. Wainwright 25th Annual Global..
8/25/202316:09EDGAR2Form 8-K - Current report
8/08/202306:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

Delayed Upgrade Clock